Epidural Versus General Anesthesia for Laparoscopic Hysterectomy
EGA-LH
Comparison of the Effects of Epidural Anesthesia and General Anesthesia on Postoperative Respiratory Function and Pain in Laparoscopic Hysterectomy
1 other identifier
interventional
70
1 country
1
Brief Summary
This randomized controlled study will compare epidural anesthesia with general anesthesia in women undergoing elective laparoscopic hysterectomy. A total of 70 participants will be randomly assigned to receive either epidural anesthesia or general anesthesia. The main aim of the study is to determine whether the type of anesthesia affects respiratory function after surgery. Respiratory function will primarily be assessed using peak expiratory flow rate (PEFR) before surgery and at 2, 6, and 24 hours after surgery. The study will also compare postoperative pain, opioid consumption, respiratory and hemodynamic parameters, recovery, mobilization, and other perioperative outcomes between the two groups. The researchers aim to determine whether epidural anesthesia may provide an alternative anesthetic approach for selected patients undergoing laparoscopic hysterectomy while maintaining spontaneous breathing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 23, 2026
CompletedFirst Posted
Study publicly available on registry
September 29, 2026
CompletedStudy Start
First participant enrolled
October 22, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
October 22, 2027
Study Completion
Last participant's last visit for all outcomes
October 22, 2027
September 29, 2026
September 1, 2026
1 year
September 23, 2026
September 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Peak Expiratory Flow Rate (PEFR)
Peak expiratory flow rate (PEFR), measured in liters per minute (L/min), will be assessed before surgery and at 2, 6, and 24 hours after surgery. The change in PEFR from the preoperative baseline will be compared between the epidural anesthesia and general anesthesia groups
Preoperative baseline and 2, 6, and 24 hours after surgery
Study Arms (2)
Epidural Anesthesia
EXPERIMENTALParticipants assigned to this arm will receive epidural anesthesia via a lumbar epidural catheter. An initial dose of 10 mL of 0.5% bupivacaine with 50 mcg fentanyl will be administered, followed by incremental doses of 2-3 mL of 0.5% bupivacaine every 5 minutes as required to achieve a T4 sensory block, up to approximately 20 mL. Spontaneous ventilation will be maintained. Dexmedetomidine will be administered at 0.2 mcg/kg/h for sedation. Conversion to general anesthesia will be performed if the epidural block is inadequate, the participant cannot tolerate the procedure, or conversion is clinically required.
General Anesthesia
ACTIVE COMPARATORParticipants assigned to this arm will receive standard general anesthesia. Anesthesia will be induced with propofol 2-2.5 mg/kg, fentanyl 1-2 mcg/kg, and rocuronium 0.6 mg/kg, followed by endotracheal intubation. Anesthesia will be maintained with sevoflurane and controlled mechanical ventilation, with end-tidal carbon dioxide maintained between 35 and 40 mmHg.
Interventions
pidural anesthesia will be administered via a lumbar epidural catheter using 0.5% bupivacaine and fentanyl. Incremental epidural doses will be administered to achieve an adequate sensory block. Spontaneous ventilation will be maintained, and dexmedetomidine will be used for sedation.
General anesthesia will be induced with intravenous propofol, fentanyl, and rocuronium, followed by endotracheal intubation. Anesthesia will be maintained with sevoflurane and controlled mechanical ventilation.
Eligibility Criteria
You may qualify if:
- Female patients aged 18-70 years
- American Society of Anesthesiologists (ASA) physical status I-III
- Body mass index (BMI) ≤30 kg/m²
- Scheduled for elective laparoscopic total hysterectomy
- Willing and able to provide informed consent
You may not qualify if:
- Contraindication to neuraxial anesthesia
- Severe cardiopulmonary disease
- BMI \>30 kg/m²
- Pre-existing neurological disorder
- Inability to cooperate with the study procedures
- Refusal to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sabiha Başarılead
Study Sites (1)
Kutahya City Hospital
Kütahya, Kütahya, 43100, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sabiha Başarı, MD
Kutahya City Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Anaesthesiology and Intensive Care Specialist
Study Record Dates
First Submitted
September 23, 2026
First Posted
September 29, 2026
Study Start (Estimated)
October 22, 2026
Primary Completion (Estimated)
October 22, 2027
Study Completion (Estimated)
October 22, 2027
Last Updated
September 29, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning 6 months after publication of the study results and available for 5 years.
- Access Criteria
- De-identified individual participant data underlying the published results may be made available to qualified researchers upon reasonable request to the corresponding author. Requests should include a scientifically sound research proposal. Data will be shared only after review and approval of the request and in accordance with applicable ethical and data protection requirements.
De-identified individual participant data that underlie the results reported in the published article may be shared upon reasonable request to the corresponding author.